RKV-21438-05144 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-20
Dose 1 — Pfizer-BioNTech
2021-04-06
Registered in v-safe
2021-04-06
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-10
Dose 2 — Pfizer-BioNTech
2021-04-10
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-11
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-07-10
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-05
Dose 3 — Pfizer-BioNTech
2022-06-05
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-12-07
Survey response — 12 months, dose 3
MedDRA: Ageusia, Anosmia — Feeling: Good

Free text: Loss of taste and smell

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-20	Pfizer-BioNTech
2	2021-04-10	Pfizer-BioNTech
3	2021-12-05	Pfizer-BioNTech	No

Free text

Release 12 — 12 months, dose 3

2022-12-07

Symptoms: Loss of taste and smell

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ageusia	·	·	✓
SD	Anosmia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release